文献速递心脑血管急症重症综合管理与镇静镇痛

肺动脉高压与成人院内心搏骤停生存及神经功能结局的关联

Association of pulmonary hypertension with survival and neurologic outcomes in adults with in-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2022-06-06
一句话结论在成人院内心搏骤停中,肺动脉高压虽提示更高风险基线特征,但与出院生存及神经功能结局无关。

该研究纳入2011至2019年在一家学术三级医疗中心接受复苏的371例成人院内心搏骤停患者,按心搏骤停前超声心动图肺动脉收缩压>35 mmHg分为肺动脉高压组(203例,54.7%)与非肺动脉高压组(168例,45.3%)。肺动脉高压组Charlson共病评分更高,多腔心扩大、左室舒张功能障碍、右室收缩功能障碍及瓣膜性心脏病更常见。两组出院生存率(11.5% vs 10.9%,p=0.881)与良好神经功能结局率(8.0% vs 6.2%,p=0.550)相似。多因素分析中,肺动脉高压与出院生存(OR 1.23,95%CI 0.57-2.65)及良好神经功能结局(OR 1.69,95%CI 0.64-4.45)均无关。

要点

  • 在371例成人院内心搏骤停中,肺动脉高压组出院生存率11.5% vs 非肺动脉高压组10.9%(p=0.881),无显著差异。
  • 良好神经功能结局(Glasgow结局评分4-5分)率肺动脉高压组8.0% vs 非肺动脉高压组6.2%(p=0.550),无显著差异。
  • 多因素分析显示肺动脉高压与出院生存无关(OR 1.23,95%CI 0.57-2.65)。
  • 多因素分析显示肺动脉高压与良好神经功能结局无关(OR 1.69,95%CI 0.64-4.45)。
  • 肺动脉高压组Charlson共病评分更高,多腔心扩大、左室舒张功能障碍、右室收缩功能障碍及瓣膜性心脏病更常见。

适用人群与场景

  • 2011至2019年在一家学术三级医疗中心接受复苏的成人院内心搏骤停患者。
  • 按心搏骤停前超声心动图肺动脉收缩压>35 mmHg分为肺动脉高压组与非肺动脉高压组。

诊断标准与关键阈值

  • 肺动脉高压定义:心搏骤停前超声心动图肺动脉收缩压>35 mmHg。
  • 良好神经功能结局定义:Glasgow结局评分4-5分。

研究设计与关键结果

  • 研究类型为在学术三级医疗中心开展的注册研究,纳入371例成人院内心搏骤停患者,其中肺动脉高压组203例(54.7%),非肺动脉高压组168例(45.3%)。
  • 肺动脉高压组Charlson共病评分更高,多种基线共病发生率更高,多腔心扩大、左室舒张功能障碍、右室收缩功能障碍及瓣膜性心脏病更常见。
  • 出院生存率:肺动脉高压组11.5% vs 非肺动脉高压组10.9%(p=0.881),无显著差异。
  • 良好神经功能结局率:肺动脉高压组8.0% vs 非肺动脉高压组6.2%(p=0.550),无显著差异。
  • 多因素分析:肺动脉高压与出院生存无关(OR 1.23,95%CI 0.57-2.65),与良好神经功能结局无关(OR 1.69,95%CI 0.64-4.45)。

证据类型、等级与局限

  • 证据类型:在单家学术三级医疗中心开展的注册研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论:肺动脉高压与更高的风险患者特征相关,但在该人群中与生存或神经功能结局无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pulmonary hypertension (PH) has been associated with poor survival in multiple cardiopulmonary conditions, however its association with outcomes in cardiac arrest remains unknown. We aimed to evaluate the association of PH with survival and neurologic outcomes in adults with in-hospital cardiac arrest (IHCA).

METHODS: The study population included adults with IHCA undergoing resuscitation at an academic tertiary-care medical center from 2011 to 2019. Patients were classified based upon the presence versus absence of PH, defined as a pulmonary artery systolic pressure >35 mmHg on pre-arrest echocardiogram. Survival to discharge and favorable neurological outcome (defined as a Glasgow Outcome Score of 4-5) served as the primary and secondary outcomes of interest respectively.

RESULTS: Of the 371 patients studied, 203 (54.7%) had PH while 168 (45.3%) did not. Patients with PH had higher Charlson Comorbidity Score with higher rates of multiple baseline comorbidities. They also had worse multi-chamber enlargement, left ventricular diastolic dysfunction, right ventricular systolic dysfunction, and valvular heart disease compared to non-PH patients. Rates of survival to discharge (11.5% vs 10.9%, p = 0.881) and favorable neurologic outcome (8.0% vs 6.2%, p = 0.550) were similar in PH and non-PH patients respectively. In multivariable analysis, PH was not associated with survival to discharge (OR 1.23, 95%CI 0.57-2.65) or favorable neurologic outcome (OR 1.69, 95%CI 0.64-4.45).

CONCLUSIONS: In this contemporary registry of adults with IHCA, while PH was associated with a higher risk patient profile, it was not associated with survival or neurologic outcomes in this population.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Patel JK, Ramkishun CA, Haw A, et al. Association of pulmonary hypertension with survival and neurologic outcomes in adults with in-hospital cardiac arrest. Resuscitation. 2022. PMID: 35671843. doi:10.1016/j.resuscitation.2022.06.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。